Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus

Elif Gülsüm Ümit1, Figen Kuloğlu, Ahmet Muzaffer Demir

  • 1Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey Phone: +90 284 235 76 41-2687

Abstract

Insights

Vancomycin-resistant enterococci (VRE) colonization is linked to B-cell malignancies and poor performance status in hematology patients. Prolonged hospitalization also increases VRE risk, independent of diagnosis or antibiotic use.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Hospital-Acquired Infections

Background:

  • Vancomycin-resistant enterococci (VRE) are significant pathogens contributing to hospital-acquired infections.
  • Risk factors for VRE colonization include extended hospitalization, broad-spectrum antibiotic use, and immunosuppression.
  • Understanding patient-specific characteristics is crucial for predicting and preventing VRE colonization in vulnerable populations.

Purpose of the Study:

  • To identify patient characteristics associated with VRE colonization in a hematology clinic.
  • To evaluate factors contributing to VRE colonization, including underlying diagnoses and performance status.

Main Methods:

  • A retrospective study analyzed data from 66 VRE-colonized and 112 non-colonized patients admitted to a hematology clinic.
  • Data collected included hematological malignancy type, gastrointestinal complaints, hypogammaglobulinemia, neutropenic enterocolitis (NEC), and performance status (ECOG and Karnofsky).
  • Statistical analysis, including logistic regression, was used to determine significant factors related to VRE colonization.

Main Results:

  • Karnofsky and ECOG performance scores were significantly associated with VRE colonization (p<0.000), with Karnofsky status being independently significant.
  • Patients with VRE colonization had higher rates of neutropenic enterocolitis (40.9% vs. 1.7%) and hypogammaglobulinemia (69.7% vs. 24.1%).
  • B-cell malignancies (lymphoma, myeloma, CLL) were prevalent among colonized patients with hypogammaglobulinemia (50%).

Conclusions:

  • B-cell malignancies, in addition to leukemia, represent a high-risk group for VRE colonization, potentially due to impaired gastrointestinal IgA from hypogammaglobulinemia.
  • Prolonged hospitalization (>7 days) is an independent risk factor for VRE colonization, irrespective of diagnosis or antibiotic exposure.
  • Poor performance status is a significant factor, possibly linked to hygiene practices and increased need for external assistance.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
93
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
727
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
399